Alluzience
Alluzience is a medicine authorised by Swissmedic under authorisation number 68145. The authorisation holder is IPSEN Pharma Schweiz GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 December 2021 and the authorisation is valid without a time limit. ATC code M03AX01 places the medicine in the group Muscle relaxants.
| Authorisation number | 68145 |
|---|---|
| Name | Alluzience |
| Full name | Alluzience, Injektionslösung |
| Authorisation holder | IPSEN Pharma Schweiz GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | M03AX01 |
| First authorisation | 10 December 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Alluzience, Injektionslösung | A | 10 December 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | M03AX01 | 01.13.0. | A |
| 2 | 2 | Durchstechflasche(n) | M03AX01 | 01.13.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Alluzience authorised in Switzerland?
Yes. Alluzience is authorised by Swissmedic under authorisation number 68145, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Alluzience have?
Alluzience is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Alluzience?
The authorisation holder is IPSEN Pharma Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.